The global cervical cancer diagnostic testing market to grow at a CAGR of 6.90% till 2020
The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages when they can be treated easily.
In the US, National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides low-cost even free cervical cancer screening for uninsured and low-income women. As per the Affordable Care Act, all health insurance plans initiated after September 23, 2010, should provide recommended cervical cancer screening tests to end-users. In developing countries, with the widespread awareness programs by public organizations like the WHO along with government initiatives, visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) are being performed to screen women. This initiative is expected to raise the market demand for cervical cancer screening and diagnostic tests.
To access the full table of contents of the report click below:
The report covers the present scenario and the growth prospects of the global cervical cancer diagnostic testing market till 2020
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Key vendors
• Abbott Molecular
• Becton
• Dickinson & Company
• Hologic
• Qiagen
• Quest Diagnostics
• Roche Molecular Diagnostics
There are 20 Chapters to deeply display the Fluoroscopy Equipment market.
To find out more of the report or request some customization : “https://www.marketintelreports.com/inquiry-before-buying.php?id=irtntr11062”
Table of Contents- Key Points Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: SEGMENTATION BY TEST TYPE
PART 06: SEGMENTATION BY METHOD
PART 07: SEGMENTATION BY END-USER
Continued…..
Complete Report Details @ “https://www.marketintelreports.com/report/irtntr11062/global-cervical-cancer-diagnostic-testing-market-20162020”
About MIR:
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Contact us for any queries on the report:
Lakshmi
Sales Manager
Email : [email protected]
Contact Sales: 1-302-261-5343
Posted by
Venkat Reddy
on Tuesday June 05 2018, 2:37 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
